Affiliation:
1. Department of Pharmaceutical Sciences, Faculty of Health and Life Sciences, North South University, Dhaka, Bangladesh
2. Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
Abstract
Background:
Alopecia areata (AA) is an autoimmune disease which results in non-scarring hair loss on the scalp or any surface with hair. Several genetic polymorphisms of the interleukin genes have been linked with this disease but the results are inconsistent. This systematic review and meta-analysis were done to find the association between rs3118470, rs2275913, rs3212227, and rs10889677 of the IL2RA, IL17A, IL12B, and IL23R genes, respectively, of the interleukin family with alopecia areata.
Methods:
A comprehensive search for relevant research articles was conducted in Pubmed, Google Scholar, and Embase databases. Our search yielded 8 relevant articles with 1940 cases and 1788 controls. The odds ratio with 95% confidence intervals was calculated using fixed effect and random effect models. Heterogeneity was determined using the Q-test and I
2 test. Publication bias was determined and funnel plots were used to adjust the odds ratio.
Results:
We found a significant risk effect for rs3118470 of the IL2RA gene with alopecia areata in the dominant model (CC + CT vs TT; OR = 1.54, 95% confidence interval = 1.05–2.26, P < .05, I
2 = 69.03%) and homozygous model (CC vs TT; OR = 2.00, 95% confidence interval = 1.07–3.71, P < .05, I
2 = 72.84%). For the other single nucleotide polymorphisms, we could not find any statistically significant association with the disease.
Conclusion:
Our analysis showed that mutation of rs3118470 of IL2RA gene possesses a significant risk effect for alopecia areata. Future studies with larger sample sizes and ethnic backgrounds are warranted to confirm our findings.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference37 articles.
1. Alopecia areata: an update on etiopathogenesis, diagnosis, and management.;Zhou;Clin Rev Allergy Immunol,2021
2. Alopecia areata. Current situation and perspectives.;Nacional Reynosa;Arch Argent Pediatr,2017
3. Alopecia areata: an updated review for 2023.;Sibbald;J Cutan Med Surg,2023
4. Alopecia areata: a multifactorial autoimmune condition.;Simakou;J Autoimmun,2019
5. Alopecia areata.;Pratt;Nat Rev Dis Prim,2017